Stock Movers

Burberry sees a boost as holiday sales soar, particularly driven by demand in China for its iconic tartan scarves and trench coats. Meanwhile, Barry Callebaut appoints a new CEO amidst challenges from record cocoa prices, resulting in a notable stock rise. On the flip side, Danone faces a significant drop following news of infant formula recalls, coupled with concerns over declining birth rates in China. It's a rollercoaster of market movements and strategic changes!

Burberry is experiencing a sales surge, especially in China, as luxury shoppers embrace classic tartan scarves and trench coats. Qiagen is attracting takeover interest, prompting a notable rise in its share price. Meanwhile, Rio Tinto reports a 5% increase in copper production, fueled by its Oyu Tolgoi operations, signaling strong market demand. The discussion further explores the strategic importance of copper amid rising needs in electronics and EVs, highlighting a trend toward consolidation in the mining sector.

Carmen Reineke, an equities reporter at Bloomberg News, dives into the latest market shifts. She highlights Netflix's 5.1% stock drop due to a cautious earnings forecast and the pause on share buybacks for a major acquisition. United Airlines impresses with a strong fourth-quarter performance and optimistic projections for 2026, fueled by high-spending travelers. Meanwhile, Boeing shows resilience, recovering from past setbacks and poised for its first annual profit in seven years as new leadership stabilizes the company.

United Airlines reports a strong fourth quarter, beating expectations with earnings of $3.10 per share, fueled by rising demand from premium and international travelers. Meanwhile, Netflix matches or exceeds revenue estimates but warns of challenges ahead, including a cautious forecast due to increased program spending and a high-stakes deal with Warner Bros. They plan to boost their content budget by 10% while pausing buybacks to fund acquisitions. Investor reactions hint at concerns about margins and free cash flow.

Emily Grafeo, a Bloomberg News CrossHouse reporter, dives into the latest market shifts. She discusses how Amazon's stock is affected by rising tariffs, as CEO Andy Jassy warns of price impacts. Netflix is making headlines with its bold move to switch to an all-cash offer for Warner Bros. Discovery, aiming to stave off a hostile takeover. Finally, Grafeo highlights Intel's recent upgrade, spurred by growing demand for AI-driven server CPUs, leading to a notable surge in its shares.

3M's profit outlook disappoints, causing shares to drop as adjusted earnings fall short of expectations. Meanwhile, MicroStrategy's massive $2.13 billion Bitcoin buy leads to stock volatility and questions about the move. In contrast, ImmunityBio sees a surge after a positive FDA meeting about its bladder cancer treatment, with heavy short interest adding to its stock's excitement. The hosts dissect the shifting market dynamics and the impacts on various sectors, providing insights into the current investment landscape.

Netflix is on the rise after securing an all-cash deal to acquire Warner Bros. Discovery’s studio and streaming business. Meanwhile, Applovin faces a slump, hit hard by a negative research report amidst a tech selloff. In contrast, Intel's shares are gaining traction thanks to an upgrade, driven by heightened demand for server CPUs from the growing field of artificial intelligence. Exciting movements in the market reflect the dynamic landscape of the tech industry!

3M's profit outlook disappoints with adjusted earnings falling below analyst expectations, highlighting a slowdown in growth momentum. Netflix shakes things up with an amended all-cash deal for Warner Bros. Discovery, igniting speculation over potential bidding wars with Paramount. Meanwhile, GSK makes headlines by agreeing to acquire Rapt Therapeutics for $2.2 billion, focusing on treatments for inflammatory diseases and food allergies. This strategic move represents a significant premium and signals GSK's shift towards immunology and oncology.

GSK is making headlines with a $2.2 billion acquisition of Rapt Therapeutics, aiming to boost its portfolio in immunologic treatments. Meanwhile, 3M is on an upward trajectory, projecting earnings growth and promising to focus on higher-growth markets. In the housing sector, D.R. Horton reports a slight miss on quarterly home orders despite easing mortgage rates, signaling mixed signals in the market. Tune in for insights on other stock movements, including Netflix's upcoming earnings and developments in M&A.

Louise Moon, Breaking News editor at Bloomberg, dives into the current state of the luxury market, highlighting LVMH's struggles amid potential U.S. tariffs on French wines. She discusses the escalating shareholder battle involving Ferretti and its ties with major investor Weichai Group. Additionally, Moon analyzes GSK's strategic $2.2 billion acquisition of Rapt Therapeutics, aimed at enhancing their pipeline for inflammatory and immunologic diseases, amidst challenges under new leadership.